|Day Low/High||135.18 / 136.25|
|52 Wk Low/High||90.64 / 135.45|
More than 936 million people have obstructive sleep apnea - the disease's first prevalence update in more than a decade - according to The Lancet Respiratory Medicine, the world's leading journal in its field.
ResMed (NYSE: RMD) (ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2019 on Thursday, July 25, 2019, after the New York Stock Exchange closes.
Jim Cramer's got the low-down on IPOs, the Fed, trade and more. Here's your game plan for next week's action.
Jim Cramer weighs in on Nucor, Wells Fargo, ResMed, Gulfport Energy, JD.com, Alibaba.
ResMed (NYSE: RMD) (ASX: RMD) revealed roughly 170 million people across North and South America have sleep apnea, according to a study it presented at the annual SLEEP meeting hosted by the American Academy of Sleep Medicine (AASM) and the Sleep Research...
ResMed (NYSE: RMD, ASX: RMD) today announced that Rob Douglas, president and chief operating officer, will participate in a fireside chat discussion at the 40 th Annual Goldman Sachs Global Healthcare Conference on Tuesday, June 11, 2019, beginning at...
ResMed (NYSE: RMD, ASX: RMD) today announced that Mick Farrell, chief executive officer, will present at the 39 th Annual William Blair Growth Stock Conference on Thursday, June 6, 2019, beginning at approximately 8:40 a.
Remote monitoring and patient self-monitoring can drive CPAP adherence for people with sleep apnea, according to research presented by ResMed (NYSE: RMD) (ASX: RMD) at the American Thoracic Society's 2019 ATS International Conference.
ResMed (NYSE: RMD, ASX: RMD) today revealed several demographic and clinical factors affect adherence to PAP (positive airway pressure) therapy, according to a study it presented at the American Thoracic Society's ATS 2019 International Conference.
ResMed (NYSE: RMD, ASX: RMD), a leader in cloud-connected medical devices and out-of-hospital SaaS solutions, today announced it has elected experienced business executive Jan De Witte to its board of directors.
Brightree ® today announced plans for its Home Health and Hospice customers to access more than 50,000 provider locations and health systems nationwide via the CommonWell Health Alliance, a nonprofit national trade association of health IT companies, and...
ResMed Inc. (NYSE: RMD, ASX: RMD), a world-leading connected health company, today announced results for its quarter ended March 31, 2019.
ResMed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2019 on Thursday, May 2, 2019, after the New York Stock Exchange closes.
ResMed (NYSE: RMD, ASX: RMD) today introduced its second top-of-head-connected CPAP mask for treating sleep apnea, a new nasal pillows option, AirFit P30i.
Brightree ® today announced that its Brightree ReSupply solution for home medical equipment (HME) providers has expanded to support additional categories outside of sleep therapy, including incontinence, diabetic, and enteral segments.
Brightree ® today introduced Advanced Analytics, the first analytics platform for HMEs that highlights workflow insights, KPI tracking, and peer benchmarking, without requiring users to aggregate data themselves.
ResMed (NYSE: RMD) (ASX: RMD) today launched its automated ResMed ReSupply solution for all U.
ResMed (NYSE: RMD) (ASX: RMD) today announced it will host an investor meeting on Thursday, April 4 th to discuss the Company's recent acquisitions, existing joint ventures and strategy pertaining to respiratory care and out-of-hospital software.
ResMed (NYSE: RMD, ASX: RMD), a global leader in cloud-connected sleep and respiratory care devices in more than 120 countries, today announced that is has completed the acquisition of HB Healthcare (HBH) to help millions of South Koreans living with...
Brightree ® today announced a new pharmacy suite for home infusion therapy providers and home medical equipment (HME) pharmacies to help them optimize business processes, more easily meet compliance requirements and provide the highest quality patient...
ResMed (NYSE: RMD, ASX: RMD), and Fisher & Paykel Healthcare (NZX: FPH, ASX: FPH) today announced an agreement to settle all outstanding patent infringement disputes between the companies in all venues around the world.
The most recent short interest data has been released for the 01/15/2019 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the S&P 500 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.
The company easily beats earnings expectations, but falls short on revenue.
ResMed Inc. (NYSE: RMD, ASX: RMD), a world-leading connected health company, today announced results for its quarter ended December 31, 2018.
ResMed (NYSE: RMD, ASX: RMD), today introduced AirFit N30i, its first top-of-head-connected nasal CPAP mask, across the United States, with a newly designed nasal cradle cushion that sits just under the wearer's nose.
ResMed (NYSE: RMD, ASX: RMD), a leader in respiratory care medical devices and out-of-hospital care software, today announced that its premier portable oxygen concentrator, Mobi, is now widely available in the United States.
ResMed (NYSE: RMD) (ASX: RMD), a leader in cloud-connected medical devices and out-of-hospital software-as-a-service (SaaS) business solutions, today announced it has completed its acquisition of Propeller Health, a digital therapeutics company providing...
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.